BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 300 participants.

Also called NCT07181590

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 300 participants (enrolled count) (from the registry)
Sponsor
  • Abbott Registry lists this organization as the lead sponsor
Registry
  • NCT NCT07181590
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Austria, Belgium, Denmark, France, Germany, Ireland, Italy, Netherlands, Poland, Portugal, Spain, Sweden (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07181590. Allocation not applicable; no masking; primary purpose treatment. Start 2025-12-11 (actual); primary completion 2027-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
Acronym
BLAST-OFF
Condition
Paroxysmal AF
Condition
Atrial Arrhythmia
Condition
Persistent Atrial Fibrillation
Intervention (Device)
Pulsed Field Ablation
Lead sponsor
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct07181590
Content hash
763feae1b0041aedf27425e37a9685f10f0fbfaf8265605aea905c3677f4d444